Uptrend in capital expenditure; Strong order visibility: Divi's will incur huge capital expenditure on new block at Unit 1 and Unit 2, with total capex of Rs1,700Cr; We initiate coverage on Divi's Laboratories with a BUY rating and target price of Rs1,900.